 |
Neovasc REDUCER-I Study Published in EuroIntervention JournalNeovasc announced the publication of an article entitled, Coronary sinus narrowing for the treatment of refractory angina: a multi-centre prospective open-label clinical study (the REDUCER-I study) in the September 2021 issue of the journal EuroIntervention |
 |
Orion Group Holdings, Inc. Announces Contract Awards of Approximately $22 Million; Value Could IncreaseOrion Group Holdings announced three contract awards totaling approximately $22 million Research, News & Market Data on Orion Group Holdings |
 |
Allegiant Receives Final BLM Approval At Flagship Eastside Project, Increasing Permitted Area By 600%Allegiant Gold announced the receipt of two permits allowing for a significant expansion of drilling and operations at its Flagship Eastside Project Research, News & Market Data on Allegiant Gold |
 |
FenixOro Drills 23.2 g/t Gold in Newly Discovered Cascada Vein, Significantly Increases Resource Potential on Northwest Corridor at Abriaqui Gold DepositFenixOro Gold announced that final assays have been received for the first three holes |
 |
Kratos Receives $3.2 Million Contract Award for Next Generation Small Engine Development for National Security ProgramKratos Defense & Security Solutions announced that its Kratos Turbine Technologies (KTT) Business has recently received an approximate $3.2 million contract award for the development of a Next Generation small engine for a National Security Program |
 |
Genprex Strengthens Management Team with Appointments of Industry Leaders Mark S. Berger, M.D. as Chief Medical Officer and Hemant Kumar, Ph.D. as Chief Manufacturing and Technology OfficerGenprex announced that the Company has strengthened its leadership team with the appointments of Mark S. Berger, M.D. to the newly-created position of Chief Medical Officer and Hemant Kumar, Ph.D., CPM, EMBA to the newly-created position of Chief Manufacturing and Technology Officer Research, News & Market Data on Genprex |
Stay up to date. Follow us:
|
